Cargando…
Advances in the management of malignancy-associated hyperuricaemia.
Acute tumour lysis syndrome (ATLS) is a metabolic derangement (hyperuricaemia, hyperphosphataemia, hyperkalaemia and hypocalcaemia) associated with lymphoproliferative malignancies. The nature and severity of the metabolic alterations are variable. Major complications are oliguric acute renal failur...
Autores principales: | Mahmoud, H. H., Leverger, G., Patte, C., Harvey, E., Lascombes, F. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2149883/ https://www.ncbi.nlm.nih.gov/pubmed/9647616 |
Ejemplares similares
-
The Management of Hyperuricaemia
por: Bayliss, Richard, et al.
Publicado: (1984) -
Favipiravir: Hyperuricaemia: case report
Publicado: (2021) -
Hyperuricaemia, gout and allopurinol in the CKD Queensland registry
por: Jeyaruban, A., et al.
Publicado: (2021) -
Hyperuricaemia and the metabolic syndrome in type 2 DM
por: Ogbera, Anthonia O, et al.
Publicado: (2010) -
Hyperuricaemia: prevalence and association with mortality in an elderly Finnish population
por: Timsans, Janis, et al.
Publicado: (2023)